跳至主要内容
临床试验/EUCTR2006-001669-41-GR
EUCTR2006-001669-41-GR进行中(未招募)不适用

PROJECT TITLE: EFFECTS OF ATORVASTATIN ON BLOOD PRESSURE AND URINARY ALBUMIN EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION - ST.A.Y

Thessaloniki's Aristoteleio University0 个研究点目标入组 50 人开始时间: 2006年11月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.LDL-C>130 or >160 mg/dL (depending on the total risk according to the most recent recommendations25).
  • 2. no previous hypolipidemic medication
  • 3. ability to provide Informed Consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. pregnancy or lactation
  • 2. myocardial infarction or unstable angina within the past 6 months
  • 3. heart failure NYHA class III-IV
  • 4. renal disease (SCr>3 mg/dL or proteinuria>3g/d)
  • 5. liver disease
  • 6. history of malignancy
  • 7. history of drug or alcohol abuse
  • 8. treatment with corticosteroids
  • 9. any other condition with poor prognosis
  • 10. inability to provide Informed Consent.

研究者

发起方
Thessaloniki's Aristoteleio University

相似试验